Boston Therapeutics, Inc.

New Filing
CIK: 0001473579·Biotechnology·DELAWARE·Filed: Jul 9, 2021
Total Offering

$8,434,778

Amount Sold

$8,434,778

Investors

5

First Sale

Jun 25, 2021

Offering Details

Type
Debt, Option to Acquire, Other: Convertible Note and Warrrants
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
David Ludvigson
Related Person
Conroy Chi-Heng Cheng
Related Person

Company

Boston Therapeutics, Inc.

354 MERRIMACK STREET #4

LAWRENCE, MA, 01843

603-935-9799

SEC Filing

0001213900-21-036321

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Boston Therapeutics, Inc. Form D Filing — $8,434,778 | FilingFlow